ScienceDaily
New weight loss pill beats oral Ozempic in major trial
Eli Lilly's orforglipron outperformed oral semaglutide on both weight loss and blood sugar control in a major head-to-head trial, marking a significant shift in the competitive landscape for GLP-1 drugs. Unlike injectable alternatives, the once-daily pill requires no refrigeration or meal restrictions, making it far more practical for everyday use. Its lower manufacturing cost could also make it a game-changer for global access to obesity treatment.
Read article βPhys.org
What to know about the total solar eclipse due in August
A total solar eclipse will sweep across northern Spain on August 12, briefly plunging the region into darkness as the moon fully obscures the sun. These events are rare enough that they draw eclipse chasers from around the world, making this a significant moment for both science and spectacle. If you're in or near the path of totality, now is the time to plan.
Read article βPhys.org
Fishing for DNA: How a cup of river water can reveal secrets about human health, pollution and biodiversity
Environmental DNA sampling is transforming how scientists study ecosystems, allowing researchers to extract a wealth of biological data from a single cup of river water. The technique can simultaneously identify wildlife populations, detect pollutants, and flag dangerous pathogens β no nets, traps, or lab animals required. As the method becomes cheaper and faster, it promises to become a frontline tool for public health monitoring and conservation.
Read article βPhys.org
Study: Biodiversity hotspots in American West face extinction
A comprehensive study of more than 1,100 springs in the American West warns that critical biodiversity hot spots are facing a mounting extinction crisis.
Read article βGet this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free β